Potent antibody drug conjugates for cancer therapy
Top Cited Papers
- 1 June 2009
- journal article
- review article
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 13 (3), 235-244
- https://doi.org/10.1016/j.cbpa.2009.03.023
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic indexNature Biotechnology, 2008
- Antibody targeting of B-cell maturation antigen on malignant plasma cellsMolecular Cancer Therapeutics, 2007
- Armed Antibodies Targeting the Mucin Repeats of the Ovarian Cancer Antigen, MUC16, Are Highly Efficacious in Animal Tumor ModelsCancer Research, 2007
- Antibody-Drug Conjugates Designed to Eradicate Tumors with Homogeneous and Heterogeneous Expression of the Target AntigenCancer Research, 2006
- Lymphocyte Activation Antigen CD70 Expressed by Renal Cell Carcinoma Is a Potential Therapeutic Target for Anti-CD70 Antibody-Drug ConjugatesCancer Research, 2006
- CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma.Clinical Cancer Research, 2006
- Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33‐positive acute myeloid leukemia in first recurrenceCancer, 2005
- A Prostate-Specific Membrane Antigen-Targeted Monoclonal Antibody–Chemotherapeutic Conjugate Designed for the Treatment of Prostate CancerCancer Research, 2004
- Tumour-targeted chemotherapy with immunoconjugates of calicheamicinExpert Opinion on Biological Therapy, 2004
- Antibody-Targeted Chemotherapy with the Calicheamicin Conjugate hu3S193- N -Acetyl γ Calicheamicin Dimethyl Hydrazide Targets Lewisy and Eliminates Lewisy-Positive Human Carcinoma Cells and XenograftsClinical Cancer Research, 2004